SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,614 | -26.9% | 43,982 | +5.4% | 0.00% | – |
| Q2 2023 | $873,716 | -50.2% | 41,745 | -49.8% | 0.00% | – |
| Q1 2023 | $1,754,680 | +67.2% | 83,082 | +101.5% | 0.00% | – |
| Q4 2022 | $1,049,144 | -73.7% | 41,224 | -75.1% | 0.00% | – |
| Q3 2022 | $3,986,000 | +64.8% | 165,873 | +32.0% | 0.00% | – |
| Q2 2022 | $2,418,000 | -26.3% | 125,656 | -33.4% | 0.00% | – |
| Q1 2022 | $3,280,000 | -20.0% | 188,743 | +0.7% | 0.00% | – |
| Q4 2021 | $4,101,000 | +45.6% | 187,349 | -46.3% | 0.00% | – |
| Q3 2018 | $2,817,000 | -28.4% | 348,653 | -37.8% | 0.00% | – |
| Q2 2018 | $3,933,000 | -50.7% | 560,202 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $7,972,000 | +29.5% | 560,202 | -20.3% | 0.00% | 0.0% |
| Q4 2017 | $6,157,000 | -52.1% | 702,844 | -36.0% | 0.00% | -50.0% |
| Q3 2017 | $12,841,000 | -31.5% | 1,097,551 | -18.2% | 0.00% | 0.0% |
| Q2 2017 | $18,743,000 | +9.3% | 1,341,644 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $17,154,000 | +61.6% | 1,250,316 | -15.5% | 0.00% | +100.0% |
| Q4 2016 | $10,612,000 | -66.6% | 1,480,047 | -29.3% | 0.00% | -75.0% |
| Q3 2016 | $31,752,000 | +53.9% | 2,094,464 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $20,630,000 | -26.1% | 2,094,464 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $27,898,000 | – | 2,094,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |